Motion - Genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: Arguments for the motion

Canadian Journal of Gastroenterology

Volumn 17, Issue 1, 2003, Pages 47-52

  Whitcomb, David C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cystic fibrosis transmembrane conductance regulator; Pancreatic secretory trypsin inhibitor; Serine protease inhibitor, Kazal type 1; Trypsin; Trypsinogen

Indexed keywords

APROTININ; SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ACUTE PANCREATITIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; FAMILY HISTORY; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENITAL MALFORMATION; HEALTH INSURANCE; HUMAN; NORTH AMERICA; PANCREAS DISEASE; PREDICTION; PRIORITY JOURNAL; SINUSITIS; VAS DEFERENS;

EID: 0037228287     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/301239     Document Type: Article

References (54)

1. Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141-5.
2. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998;339:653-8.
3. Sharer N, Schwarz M, Malone G, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-52.
4. Witt H, Luck W, Hennies HC, et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-6.
5. Pfützer RH, Barmada MM, Brunskill APJ, et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000;119:615-23.
6. Rinderknecht H. Pancreatic secretory enzymes. In: Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The Pancreas: Biology, Pathobiology, and Disease, 2nd edn. New York: Raven Press, 1993:219-51.
7. Whitcomb DC. Hereditary pancreatitis: New insights into acute and chronic pancreatitis. Gut 1999;45:317-22.
8. Whitcomb DC. Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am 2000;84:531-47.
9. Gorry MC, Gabbaizedeh D, Furey W, et al. Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology 1997;113:1063-8.
10. Pfützer RH, Whitcomb DC. Trypsinogen mutations in chronic pancreatitis. Gastroenterology 1999;117:1507-8. (Lett)
11. Antonarakis SE, and the Nomenclature Working Group. Recommendations for a nomenclature system for human gene mutations. Hum Mutat 1998;11:1-3.
12. Varallyay E, Pal G, Patthy A, Szilagyi L, Graf L. Two mutations in rat trypsin confer resistance against autolysis. Biochem Biophys Res Commun 1998;243:56-60.
13. Sahin-Toth M. Hereditary pancreatitis-associated mutation asn(21) → ile stabilizes rat trypsinogen in vitro. J Biol Chem 1999;274:29699-704.
14. Howes N, Greenhalf W, Rutherford S, et al. A new polymorphism for the R117H mutation in hereditary pancreatitis. Gut 2001;48:247-50.
15. Pfützer RH, Myers E, Applebaum-Shapiro SE, et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut 2002;50:271-2.
16. Finch MD, Howes N, Ellis I, et al. Hereditary pancreatitis and familial pancreatic cancer. Digestion 1997;58:564-9.
17. Ferec C, Raguenes O, Salomon R, et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999;36:228-32.
18. Teich N, Ockenga J, Manus MP, Mössner J, Keim V. Evidence for further mutations of the cationic trypsinogen in hereditary pancreatitis. Digestion 1999;60:401. (Abst)
19. Nishimori I, Kamakura M, Fujikawa-Adachi K, et al. Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis. Gut 1999;44:259-63.
20. Lowenfels AB, Maisonneuve P, Whitcomb DC, Lerch MM, DiMagno EP. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169-70.
21. Applebaum SE, Kant JA, Whitcomb DC, Ellis IH. Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am 2000;82:575-88.
22. Applebaum-Shapiro SE, Peters JA, O'Connell JA, Aston CE, Whitcomb DC. Motivations and concerns of patients with access to genetic testing for hereditary pancreatitis. Am J Gastroenterol 2001;96:1610-7.
23. Etemad B, Whitcomb DC. Chronic pancreatitis: Diagnosis, classification, and new genetic developments. Gastroenterology 2001;120:682-707.
24. Lowenfels A, Maisonneuve P, DiMagno E, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6.
25. Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: Guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001;1:405-15.
26. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989;245:1066-73.
27. Durie PR. Pancreatitis and mutations of the cystic fibrosis gene. N Engl J Med 1998;339:687-8. (Lett)
28. Tsui LC, Durie P. Genotype and phenotype in cystic fibrosis. Hosp Pract 1997;32:115-8.
29. Macek M Jr, Mackova A, Hamosh A, et al. Identification of common cystic fibrosis mutations in African-Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet 1997;60:1122-7.
30. Zielenski J, Tsui LC. Cystic fibrosis: Genotypic and phenotypic variations. Ann Rev Genet 1995;29:777-807.
31. Durie PR. Pancreatic aspects of cystic fibrosis and other inherited causes of pancreatic dysfunction. Med Clin North Am 2000;84:609-20.
32. Chillon M, Casals T, Mercier B, et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332:1475-80.
33. Strong TV, Wilkinson DJ, Mansoura MK, et al. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum Mol Genet 1993;2:225-30.
34. Costes B, Girodon E, Ghanem N, et al. Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet 1995;3:285-93.
35. Gomez Lira M, Benetazzo MG, Marzari MG, et al. High frequency of cystic fibrosis transmembrane regulator mutation L997F in patients with recurrent idiopathic pancreatitis and in newborns with hypertrypsinemia. Am J Hum Genet 2000;66:2013-4.
36. Lowenfels A, Maisonneuve P, Palys B. Re: Ockenga et al - Mutations of cystic fibrosis gene in patients with pancreatitis. Am J Gastroenterol 2001;96:614-5. (Lett)
37. Cohn JA, Bornstein JD, Jowell PS. Cystic fibrosis mutations and genetic predisposition to idiopathic chronic pancreatitis. Med Clin North Am 2000;84:621-31.
38. Massie RJ, Wilcken B, Van Asperen F, et al. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels. J Pediatr 2000;137;214-20.
39. Anguiano A, Oates RD, Amos JA, et al. Congenital bilateral absence of the vas deferens. A primary genital form of cystic fibrosis. JAMA 1992;267:1794-7.
40. Wang X, Moylan B, Leopold DA, et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA 2000;284:1814-9.
41. Owyang C, Levitt M. Chronic pancreatitis. In: Yamada T, ed. Textbook of Gastroenterology. Philadelphia: J.B. Lippincott, 1991:1874-93.
42. Whitcomb DC, Ulrich CD, Lerch MM, et al. Third International Symposium on Inherited Diseases of the Pancreas. Pancreatology 2001;1:423-31.
43. Rinderknecht H, Adham NE, Renner IG, Carmack C. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion. Int J Pancreat 1988;3:33-44.
44. Chen J-M, Mercier B, Audrezet M-P, Ferec C. Mutation analysis of the human pancreatic secretory inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000;37:67-9.
45. Pfützer RH, Finch R, Shapiro SE, et al. Mutations in the SPINK1 gene modify the phenotypic expression of hereditary pancreatitis caused by cationic trypsinogen (PRSS1) mutations R122H and N291. Gastroenterology 2001;120:A33. (Abst)
46. Schiezer J. Genetic underclass emerging. Intern Med World Rep 2001;16:22.
47. Böhm A-K, Reinheckel T, Rosenstrauch D, Halangk W, Schulz HU. Screening for a point mutation of cationic trypsinogen in patients with pancreatic disease. Digestion 1999;60:369. (Abst)
48. Cohn JA, Bornstein JD, Jowell PJ, et al. Molecular pathogenesis of chronic pancreatitis associated with abnormal CFTR genotypes. Gastroenterology 2000;118:A159. (Abst)
49. Creighton J, Lyall R, Wilson DI, Curtis A, Charnley R. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 1999;354:42-3. (Lett)
50. Sibert JR. Hereditary pancreatitis in England and Wales. J Med Genet 1978;15:189-201.
51. Perrault J. Hereditary pancreatitis. Gastroenterol Clin North Am 1994;23:743-52.
52. Whitcomb DC, Ulrich CD Jr. Hereditary pancreatitis: New insights, new directions. Best Pract Res Clin Gastroenterol 1999;13:253-63.
53. Sossenheimer MJ, Aston CE, Preston RA, et al. Clinical characteristics of hereditary pancreatitis in a large family based on high-risk haplotype. The Midwest Multicenter Pancreatic Study Group (MMPSG). Am J Gastroenterol 1997;92:1113-6.
54. Paolini O, Hastier P, Buckley M, et al. The natural history of hereditary chronic pancreatitis: a study of 12 cases compared to chronic alcoholic pancreatitis. Pancreas 1998;17:266-71.